Diabetologia

Article	Citations
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)	412
Hypoxia and hypoxia-inducible factors in diabetes and its complications	197
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses	170
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)	164
New closed-loop insulin systems	154
Interpreting global trends in type 2 diabetes complications and mortality	153
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies	143
Sex differences in type 2 diabetes	126
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis	123
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study	118
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial	114
Incidence of newly diagnosed diabetes after Covid-19	113
Defining the underlying defect in insulin action in type 2 diabetes	107
Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults	106
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission	90
The consequences of hypoglycaemia	87
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease	85
Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants	85
Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature	81
Current and future therapies for type 1 diabetes	76
Environmental risk factors of type 2 diabetes—an exposome approach	72
A global perspective on the issue of access to insulin	70
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment	68
The promise of stem cell-derived islet replacement therapy	66
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis	64

Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis	63
Pancreatic beta cell autophagy is impaired in type 1 diabetes	63
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes	61
The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials	58
Diabetes and the COVID-19 pandemic	57
Evidence-based European recommendations for the dietary management of diabetes	57
The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial	55
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues	55
Cardiovascular outcomes in type 1 and type 2 diabetes	54
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial	53
M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice	53
The expanding incretin universe: from basic biology to clinical translation	51
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings	51
Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990–2019 data	48
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial	48
Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction	48
Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study)	48
Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice	47
Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial	47
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study	47
Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes	47
HDL and type 2 diabetes: the chicken or the egg?	46
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study	46
Diabetic retinopathy screening in the emerging era of artificial intelligence	45
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits	45
Structural and functional polarisation of human pancreatic beta cells in islets from organ donors with and without type 2 diabetes	44
Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function	43
Consensus report: definition and interpretation of remission in type 2 diabetes	42
Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control	42
Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver	41
Hypothalamic glucose-sensing mechanisms	41
Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews	40
Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity	40
Lifetime risk of diabetes in metropolitan cities in India	39
Realising the long-term promise of insulin therapy: the DCCT/EDIC study	39
BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study	39
Consequences of recurrent hypoglycaemia on brain function in diabetes	39
Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls	38
Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial	37
Exercise training improves mitochondrial respiration and is associated with an altered intramuscular phospholipid signature in women with obesity	37
Depression, diabetes, comorbid depression and diabetes and risk of all-cause and cause-specific mortality: a prospective cohort study	37
Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation—relevance for (pre)diabetes: The Maastricht Study	37
Involvement of circHIPK3 in the pathogenesis of diabetic cardiomyopathy in mice	36
Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies	36
Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondar	35
Impact of insufficient sleep on dysregulated blood glucose control under standardised meal conditions	34
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial	34
Phenotypic and genetic classification of diabetes	34
Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes	34
Precision prognostics for the development of complications in diabetes	33

100 years of glucagon and 100 more	33
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy	33
Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the A	33
Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts	33
Incretin hormones and type 2 diabetes	33
Mediators of the association between educational attainment and type 2 diabetes mellitus: a two-step multivariable Mendelian randomisation study	32
Artificial intelligence utilising corneal confocal microscopy for the diagnosis of peripheral neuropathy in diabetes mellitus and prediabetes	32
Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors	32
Unravelling innervation of pancreatic islets	32
Maturation of beta cells: lessons from in vivo and in vitro models	32
Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor	31
The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review	31
Two decades since the fetal insulin hypothesis: what have we learned from genetics?	31
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade	31
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial	31
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes	31
Metabolic, structural and biochemical changes in diabetes and the development of heart failure	30
SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism	30
Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study	30
Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes	29
Pharmacogenetics of novel glucose-lowering drugs	29
Development and validation of a cardiovascular risk prediction model in type 1 diabetes	28
Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study	28
Analysis of overlapping genetic association in type 1 and type 2 diabetes	28
Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study	28
XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice	27
Lifestyle interventions in pregnancy targeting GDM prevention: looking ahead to precision medicine	27
Diabetes and the risk of hospitalisation for infection: the Atherosclerosis Risk in Communities (ARIC) study	27
Sodium–glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia–reperfusion injury: a meta-analysis	27
Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study	27
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control	27
Timing of physical activity in relation to liver fat content and insulin resistance	27
Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation	27
The liver–alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels	27
High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease	27
Improved transition to adult care in youth with type 1 diabetes: a pragmatic clinical trial	27
High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice	26
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus	26
Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data	26
Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy	26
Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo	26
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts	26
Associations of polysocial risk score, lifestyle and genetic factors with incident type 2 diabetes: a prospective cohort study	26
Do variations in insulin sensitivity and insulin secretion in pregnancy predict differences in obstetric and neonatal outcomes?	26
Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: the Edinburgh Type 2 Diabetes Study	25
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study	25
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial	25
Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time	24
Brain JNK and metabolic disease	24
Precision nutrition in diabetes: when population-based dietary advice gets personal	24
Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland	24
Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study	24
Sodium–glucose cotransporter 2 inhibitors and risk of nephrolithiasis	24
Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes	24
Associations of plasma glycerophospholipid profile with modifiable lifestyles and incident diabetes in middle-aged and older Chinese	24
Social networks and type 2 diabetes: a narrative review	24
Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes	24
Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)	24
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study	24
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a rando	23
A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome	23
Ketones: the double-edged sword of SGLT2 inhibitors?	23
Type 2 diabetes burden among migrants in Europe: unravelling the causal pathways	23
Obesity in late adolescence and incident type 1 diabetes in young adulthood	23
Do gene–environment interactions have implications for the precision prevention of type 2 diabetes?	23
Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study	23
Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults	23
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT	23
Outdoor light at night in relation to glucose homoeostasis and diabetes in Chinese adults: a national and cross-sectional study of 98,658 participants from 162 study sites	22
BMI and risk of gestational diabetes among women of South Asian and Chinese ethnicity: a population-based study	22
Dietary palmitate and oleate differently modulate insulin sensitivity in human skeletal muscle	22
Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England	22
Reducing intergenerational obesity and diabetes risk	22
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement	22
Intestinal lipid absorption and transport in type 2 diabetes	22
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy	22
Somatosensory network functional connectivity differentiates clinical pain phenotypes in diabetic neuropathy	22
Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats	22
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes	22
Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women’s Health Across the Nation (SWAN)	22

IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes	22
Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study	22
Precision medicine in type 1 diabetes	22
Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system	21
Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function	21
Socioeconomic aspects of incretin-based therapy	21
Postpartum circulating microRNA enhances prediction of future type 2 diabetes in women with previous gestational diabetes	21
Liver-targeting drugs and their effect on blood glucose and hepatic lipids	21
Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease	21
Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetes	20
Maternal diet quality during pregnancy is associated with biomarkers of metabolic risk among male offspring	20
Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening	20
IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes	20
Branched-chain amino acid metabolism is regulated by ERRα in primary human myotubes and is further impaired by glucose loading in type 2 diabetes	20
Causal factors underlying diabetes risk informed by Mendelian randomisation analysis: evidence, opportunities and challenges	20
Lipotoxicity-induced circGlis3 impairs beta cell function and is transmitted by exosomes to promote islet endothelial cell dysfunction	20
The legacy effect in diabetes: are there long-term benefits?	20
Risk of type 2 diabetes mellitus in women with prior hypertensive disorders of pregnancy: a systematic review and meta-analysis	20
Early-life exposure to the Chinese famine, genetic susceptibility and the risk of type 2 diabetes in adulthood	20
A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER	20
Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice	20
When therapeutic drugs lead to diabetes	19
Fasting glucose, bone area and bone mineral density: a Mendelian randomisation study	19
Pancreatic alpha cell glucagon–liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes	19
Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century	19
Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes	19
Urban–rural disparities in diabetes-related mortality in the USA 1999–2019	19
Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry	19
Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes	19
Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies	19
Lessons from single-cell RNA sequencing of human islets	19
Healthful eating patterns, serum metabolite profile and risk of diabetes in a population-based prospective study of US Hispanics/Latinos	19
Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis	19
Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervent	19
Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study	18
Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetes	18
Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity	18
Infant gut microbiome composition correlated with type 1 diabetes acquisition in the general population: the ABIS study	18
A roadmap to achieve pharmacological precision medicine in diabetes	18
Mucosal-associated invariant T cells are associated with insulin resistance in childhood obesity, and disrupt insulin signalling via IL-17	18
Maternal obesity during pregnancy leads to adipose tissue ER stress in mice via miR-126-mediated reduction in Lunapark	18
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus	18
Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cells	18
Association between diabetes and haematological malignancies: a population-based study	18
Sitting less elicits metabolic responses similar to exercise and enhances insulin sensitivity in postmenopausal women	18
Racial differences in all-cause mortality and future complications among people with diabetes: a systematic review and meta-analysis of data from more than 2.4 million individuals	18
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes	18
SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study	18
A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection	17
Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study	17
Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study	17
Gut microbiota mediate melatonin signalling in association with type 2 diabetes	17
The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation	17
HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study	17
Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity	17
Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis	17
The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells	17
Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus	17
Association of maternal diabetes during pregnancy with high refractive error in offspring: a nationwide population-based cohort study	17
Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity	16
The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)	16
Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study	16
Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes	16
Low birthweight is associated with a higher incidence of type 2 diabetes over two decades independent of adult BMI and genetic predisposition	16
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease	16
Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes	16
Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity	16
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study	16
Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans	16
Associations between plasma kynurenines and cognitive function in individuals with normal glucose metabolism, prediabetes and type 2 diabetes: the Maastricht Study	16
Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway	16
Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice	16
Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes	16
Characterising the age-dependent effects of risk factors on type 1 diabetes progression	16
Overexpression of d-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats	16
Altered blood gene expression in the obesity-related type 2 diabetes cluster may be causally involved in lipid metabolism: a Mendelian randomisation study	16
Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes	16
Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG	16
Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk	16
Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification	16
Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study: newborn anthropometrics and childhood glucose metabolism	15
Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes	15
Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China	15
MicroRNA biomarkers of type 2 diabetes: evidence synthesis from meta-analyses and pathway modelling	15
Habitual exercise is associated with reduced risk of diabetes regardless of air pollution: a longitudinal cohort study	15
Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people	15
Glucolipotoxicity promotes the capacity of the glycerolipid/NEFA cycle supporting the secretory response of pancreatic beta cells	15
Pathophysiology of type 2 diabetes in sub-Saharan Africans	15
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study	15
Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy	15
Genetics of diabetes-associated microvascular complications	15
Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes	15
Assessing data on the incidence of lower limb amputation in diabetes	15